17 Aug 2021

Updated 2 Nov 2021

Virtual Clinical Trials – Unifying Trials from Patient Engagement Through Study Closeout


Virtual Clinical Trials – Unifying Trials from Patient Engagement Through Study Closeout

Are you interested in Virtual Trials? You have heard about it, but not sure whether this approach is the most appropriate for you? You want to know how to increase patient compliance and data quality?

We are happy to announce our upcoming webinar at XTalks on Monday, September 20, 2021, 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central):

Modern Clinical trials have undergone a huge shift in the need for fit for purpose technology; It is more important than ever to have your patient engagement activities unified with your data management. The shift towards technology has increased the importance of a single vendor to cover those needs. In this webinar, EvidentIQ will show you how you can have a fully unified Clinical Trial including eConsent, eCOA, EDC, IWRS, CTMS, eTMF and so much more. Being able to have one vendor and one software platform to cover the entirety of your clinical trial ensures consistent ROI, consistency of support, as well as user and customer adoption. Training times are lowered, users are empowered and the data quality on the other side is so much higher.

Register now for free to hear our experts defining EvidentIQ’s approach to virtual trials.

This webinar will show you how we:

  • Ensure consistent fast study ROI and patient ROI
  • Eliminate paper from all aspects of your trial
  • Reduce the site monitoring burden where possible with reduced source document validation
  • Increase patient compliance and data quality with intuitive, easy to use, compliant data capture technology

    Our Speakers:

Simon Taylor is the Head of Solution Consulting at EvidentIQ, focussing on demonstrating our unified suite to prospects and customers alike. His background is across the eClinical spectrum including Clinical Operations and data management. Simon started his career in Regulatory Affairs before bridging into the world of software.

Andreas Weber is CEO at EvidentIQ Group GmbH. With a strong background in Strategy Consulting, Andreas Weber has been supporting the Life Sciences industry for more than 20 years. He looks back on a career with top management positions at ERT, Bioclinica and Oracle Health Sciences.

EvidentIQ is a joining of best of breed applications across the areas of Real World evidence, patient engagement and Clinical Trial Data Management. Our goal is to bring the industry into a single unified platform across the entire trial lifecycle, including Patient Insights, Clinical Data Management as well as Clinical Study and document Management. All of this is covered within one, Unified, Cloud based Platform.

Book your spot by registering. We hope you and your colleagues will join us!

EvidentIQ is a next generation technology-amplified data science group championing new standards in value creation and innovation driven relevance for customers. The EvidentIQ offering brings a pioneering end-to-end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform. By combining its platform with a broad data science service portfolio such as patient recruitment, patient engagement media and a host of RWE late phase solutions EvidentIQ significantly helps customers optimize HTA submissions, pricing and reimbursement needs.

EvidentIQ supports 15 of the top 20 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.

Contact us for more information: 

Image Credit:Foto istock by metamorworks

Get a Demo

Let us show you how we can help you.

Get a Quote

Discover a solution tailored to your needs and budget.

Get a Meeting

Let’s start a new project together!

Let’s Start
a conversation

Ready to discover how our platform and its suite of applications can meet your needs?


    We use cookies to personalize content and ads, provide social media features, and analyze traffic to our website. Our partners may combine this information with other data they have provided to you or collected from your use of the services. Because we value your privacy, we hereby request your permission to use the following technologies. You may change / revoke your consent later at any time by clicking on the settings in the lower left corner of the page.

    Please note that according to a recent ruling by the European Court of Justice (ECJ), there is no adequate level of data protection in the USA and therefore a risk to the protection of your data. For example, under certain conditions, your data may be processed by US authorities for control and monitoring purposes. In addition, we currently refer to Art. 49 GDPR with regard to the legal basis for the transfer of data. After implementation of the new EU standard data protection clauses, these will constitute the legal basis for data transfer to third countries.